Fairmount Funds Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,543,107	Closed	-$29.2M	–	18
2022 Q4	$29.2M	Hold	2,543,107	–	–	4.63%	8
2022 Q3	$32M	Sell	2,543,107 -800,000	-24%	-$10.1M	5.63%	4
2022 Q2	$35.4M	Buy	+3,343,107	New	+$35.4M	8.1%	3